Statewide—Lt. Governor Suzanne Crouch, along with Treasurer Kelly Mitchell and the Indiana Arts Commission announced details for the 2020 Hoosier Women Artists contest.“This is one of the highlights of my job, and one that I look forward to every year,” said Crouch. “Each artist has their own unique story and they always find a beautiful way to express themselves. I cannot wait to see the artwork this year and meet the incredible and talented women behind the pieces.”Since 2008, the Hoosier Women Artists program has celebrated and further expanded the important role art plays in our communities by showcasing the work of talented women artists throughout the state.The theme of the 2020 Hoosier Women Artists competition will be a celebration of women and commemoration of the women’s suffrage centennial anniversary. Artists are encouraged to submit pieces related to this theme, expressed in the artists’ own interpretation. Mitchell said winners of the Hoosier Women Artists contest will have their artwork displayed in her office and the Lt. Governor’s office at the statehouse for one year to be enjoyed by the thousands of school groups, visitors and staff who explore the building annually.Additionally, pieces of art will also be selected by First Lady Janet Holcomb, Secretary of State Connie Lawson, Auditor Tera Klutz, Chief Justice Loretta Rush and Superintendent of Public Instruction Jennifer McCormick to display in their respective offices and the Governor’s residence.Submissions may be made on the Indiana Art Commission’s Onine Application System from today through January 31, 2020. Applicants will need to create a username and password and select Hoosier Women Artists as the program name.Requirements include:Framed wall art only;Maximum dimensions (including frame): 42” x 60”;Maximum weight: 60 lbs.;Must be installation-ready, including frame and hanging wires; andSubmit one entry per artist to be considered.A reception will be held on March 4, 2020, at the Indiana Statehouse to honor the selected artists.
Researchers on Wednesday released some encouraging news about a possible treatment for coronavirus.They announced that the experimental drug remdesivir could help patients recover more quickly.The U.S. Food and Drug Administration says it is in discussions with Gilead Sciences, the maker of the drug, about making it available to patients.“As part of the FDA’s commitment to expediting the development and availability of potential COVID-19 treatments, the agency has been engaged in … discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate,” FDA spokesman Michael Felberbaum said in statement.The government-funded study found that patients who took remdesivir recovered faster than patients who did not.Additionally, the head of the National Institute of Allergy and Infectious Diseases is optimistic about those results.“The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery,” Fauci said at the White House during a meeting with President Trump on Wednesday. He added, “What [the clinical trial] has proven is that a drug can block this virus. This drug happens to be blocking an enzyme that the virus uses.”Fauci, who has been at the head of the agency for 36 years, compared the findings to the 1986 discovery that the anti-retroviral drug azidothymidine, or AZT, could suppress the HIV virus in patients with AIDS. That drug, which later became known as Retrovir, allowed for HIV patients to turn what was often considered a terminal illness into a manageable chronic health condition.Results from the preliminary trial show remdesivir improved recovery time for coronavirus patients from 15 to 11 days, similar to the effect Tamiflu has on flu.“Although a 31% improvement doesn’t seem like a knockout 100%, it is very important proof of concept,” Fauci added.“Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group,” the NIAID said.There is no word on when the FDA may approve the drug for use.
According to reports this morning the governing body were unwilling to offer the Nenagh native an extension to his central contract due to his age, much to the displeasure of Munster.Ryan turns 34 in December, but the province are believed to be unhappy with the reasoning given Jamie Heaslip – who is one week older – had his contract extended last month.The second row is set to link up with Ronan O’Gara at Racing 92 from the start of next season. Meanwhile, Munster are giving Conor Murray “every opportunity” to prove his fitness ahead of Saturday’s European Champions Cup quarter-final against Toulouse.The scrum-half missed Ireland’s final Six Nations game against England due to an injury he picked up the previous week against Wales.